R. Vuylsteke

发表

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node

E. Rutgers, T. D. de Gruijl, H. Stockmann, 2019, Journal of Immunotherapy for Cancer.

Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.

D. Busch, S. Meijer, T. D. de Gruijl, 2002, The American journal of pathology.

Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry

P. V. van Diest, H. Gietema, S. Meijer, 2004, Journal of Clinical Pathology.

Feasibility of flowcytometric quantitation of immune effector cell subsets in the sentinel lymph node of the breast after cryopreservation.

T. D. de Gruijl, H. Stockmann, H. Bril, 2012, Journal of immunological methods.

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials

T. D. de Gruijl, P. V. van Leeuwen, R. Scheper, 2017, Clinical Cancer Research.

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma

P. V. van Diest, E. D. L. de Lange-de Klerk, S. Meijer, 2001, Cancer.

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation

T. D. de Gruijl, K. Jooss, S. Lougheed, 2022, Science Immunology.

Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.

S. Meijer, T. D. de Gruijl, P. V. van Leeuwen, 2005, The American journal of pathology.

Technical Advance Sampling Tumor-Draining Lymph Nodes for Phenotypic and Functional Analysis of Dendritic Cells and T Cells

D. Busch, S. Meijer, P. V. Leeuwen, 2002 .

Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study)

W. Bemelman, M. Dijkgraaf, J. Burger, 2017, Annals of surgery.

Is major liver surgery associated with an increased systemic inflammatory response? A prospective comparison of hemihepatectomy and other major abdominal surgery.

M. Cuesta, C. Hack, S. Meijer, 1999, Liver.

Local Administration of Granulocyte/Macrophage Colony-stimulating Factor Increases the Number and Activation State of Dendritic Cells in the Sentinel Lymph Node of Early-Stage Melanoma

P. V. van Diest, H. Gietema, S. Meijer, 2004, Cancer Research.

Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results.

H. Gietema, S. Meijer, P. V. van Leeuwen, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and immunological aspects of the sentinel lymph node procedure in melanoma

R. Vuylsteke, 2006 .

Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients

P. Diest, S. Meijer, R. Nijveldt, 2002, World Journal of Surgery.

Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway

T. D. de Gruijl, H. Stockmann, M. P. van den Tol, 2020, Journal for ImmunoTherapy of Cancer.

Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients.

G. Meijer, S. Meijer, T. Geijtenbeek, 2006, Immunobiology.

In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma

T. D. de Gruijl, A. V. D. van den Eertwegh, B. Sluijter, 2019, Oncoimmunology.

Sentinel Lymph Node Tumor Load: An Independent Predictor of Additional Lymph Node Involvement and Survival in Melanoma

H. Gietema, P. Diest, S. Meijer, 2005, Annals of Surgical Oncology.

Predicting Nonsentinel Lymph Node Involvement in Stage I/II Melanoma

H. Gietema, P. Diest, S. Meijer, 2003, Annals of Surgical Oncology.

No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm

P. V. van Diest, S. Meijer, P. V. Leeuwen, 2001, Melanoma research.

Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF–Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content

S. Meijer, J. Haanen, T. D. de Gruijl, 2006, Clinical Cancer Research.

Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.

B. Molenkamp, R. Vuylsteke, M. S. Statius Muller, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Predicting Nonsentinel Lymph Node Involvement in Stage I/II Melanoma

H. Gietema, R. Vuylsteke, PhD P. J. van Diest MD, 2003, Annals of Surgical Oncology.

Unpredictability of lymphatic drainage patterns in melanoma patients

S. Meijer, P. V. van Leeuwen, R. Pijpers, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Small Bowel Perforation Caused by Advanced Melanoma

H. Stockmann, E. Vermeulen, I. Thomassen, 2014, Tumori.

Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study)

W. Bemelman, M. Dijkgraaf, J. Burger, 2021, Annals of surgery.

Randomized controlled multicentre study comparing biological mesh closure of the pelvic floor with primary perineal wound closure after extralevator abdominoperineal resection for rectal cancer (BIOPEX-study)

W. Bemelman, M. Dijkgraaf, J. Burger, 2014, BMC Surgery.

Repair of a coccygeal hernia with a biological mesh

R. Vuylsteke, F. Hoexum, 2014, International journal of surgery case reports.

Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

T. D. de Gruijl, P. V. van Leeuwen, R. Scheper, 2015, Journal of Immunotherapy for Cancer.

Clinical and immunological aspects of the sentinel lymph node procedure in melanoma

R. Vuylsteke, 2006 .